Standard BioTools Inc.LABNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+73.5%/yr
vs +73.1%/yr prior
Acceleration
+0.4pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
5.2x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 155.30% |
| Q3 2025 | -0.67% |
| Q2 2025 | -28.57% |
| Q1 2025 | 22.22% |
| Q4 2024 | -28.57% |
| Q3 2024 | 41.67% |
| Q2 2024 | 55.56% |
| Q1 2024 | -8.00% |
| Q4 2023 | 7.41% |
| Q3 2023 | -22.73% |
| Q2 2023 | -4.76% |
| Q1 2023 | 19.23% |
| Q4 2022 | 29.73% |
| Q3 2022 | 54.88% |
| Q2 2022 | 17.17% |
| Q1 2022 | -725.00% |
| Q4 2021 | 33.33% |
| Q3 2021 | 21.74% |
| Q2 2021 | 8.00% |
| Q1 2021 | -4.17% |
| Q4 2020 | -189.86% |
| Q3 2020 | 54.00% |
| Q2 2020 | 21.74% |
| Q1 2020 | -27.78% |
| Q4 2019 | 5.26% |
| Q3 2019 | 5.00% |
| Q2 2019 | 54.55% |
| Q1 2019 | -22.22% |
| Q4 2018 | 5.26% |
| Q3 2018 | 9.52% |
| Q2 2018 | -23.53% |
| Q1 2018 | -25.93% |
| Q4 2017 | 41.30% |
| Q3 2017 | 20.69% |
| Q2 2017 | 1.69% |
| Q1 2017 | 3.28% |
| Q4 2016 | 10.29% |
| Q3 2016 | -6.25% |
| Q2 2016 | 7.25% |
| Q1 2016 | -53.33% |